Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Moderately high prolactin levels do not cause hair loss in women.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Understanding how acne develops in different diseases could lead to new treatments.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.